OVX836 480µg
OVX836-004
Phase 2 mab completed
Quick answer
OVX836 480µg for Influenza is a Phase 2 program (mab) at Harmony Biosciences Holdings with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Harmony Biosciences Holdings
- Indication
- Influenza
- Phase
- Phase 2
- Modality
- mab
- Status
- completed